Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation (Tables)

v3.25.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Stock-Based Compensation Expense for Stock Options Granted to Employees and Non-Employees

The following table summarizes the stock-based compensation expense for stock options granted to employees and non-employees:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Research and development

 

$

1,672,560

 

*

$

84,370

 

 

$

3,781,582

 

*

$

94,594

 

Selling, general and administrative

 

 

2,852,646

 

 

 

63,654

 

 

 

6,994,562

 

 

 

137,561

 

Total stock-based compensation expense

 

$

4,525,206

 

 

$

148,024

 

 

$

10,776,144

 

 

$

232,155

 

 

*Includes $0.7 million and $1.8 million for the three and nine months ended September 30, 2025, respectively, related to the restricted stock awards issued in connection with the acquisition of CorHepta.